“The reality is the vaccine approval this week is not going to really impact that, I think, to any degree for the next 60 days,” Redfield said.
The US Food and Drug Administration moved ever closer to approving emergency use of the coronavirus vaccine developed by Pfizer with its German partner BioNTech.
“The FDA informed Pfizer that they do intend to proceed towards an authorisation for their vaccine,” Health and Human Services Secretary Alex Azar told ABC News on Friday.
“We will work with Pfizer to get that shipped out so we could be seeing people getting vaccinated Monday or Tuesday,” Azar said.
Britain and Canada have already approved the Pfizer vaccine, and the US advisory panel is due to review a second vaccine, from Moderna Inc, next week. Other vaccine candidates are in the works.
Healthcare workers, first responders and nursing home residents are expected to receive the first doses, but a wider rollout faces significant logistical challenges to meet President-elect Joe Biden’s goal of inoculating 100 million people within 100 days of his inauguration on January 20.
“It’s not going to be like a light switch on and off. It’s going to be more like a dimmer switch,” said Dr Mark Mulligan, director of the NYU Langone Health Vaccine Centre and a lead investigator for the Pfizer trials.
Dr Michael Osterholm, a member of Biden’s coronavirus advisory board, told CNN it would be several months before the nation sees widespread availability of vaccines.
Then there is the American scepticism about vaccines, with only 61 per cent saying they are open to getting vaccinated, according to a Reuters/Ipsos poll.
Moreover, American women, who traditionally make most of the healthcare decisions in their families, are more wary than men as the survey showed 35 per cent were “not very” or “not at all” interested in getting a vaccine.
In the meantime, grim statistics continue to pile up as the United States recorded more than 200,000 cases per day for four straight days with another 220,815 cases on Thursday, according to a Reuters tally of official data.
The United States has so far reported about 15.6 million cases and 292,642 deaths by Thursday.
That death toll is likely to top 500,000 by April, according to the model developed by the University of Washington’s Institute for Health Metrics and Evaluation.
Deaths could be limited to an estimated 482,000 with a rapid vaccine rollout, but could also soar to nearly 600,000 if more state and local governments ease mandates to wear masks.
By comparison, heart disease killed 655,381 people in the United States and cancer 599,274 in 2018, according to CDC data.
Get our Coronavirus Update newsletter
Stay across the news you need to know related to the pandemic. Sent Monday and Thursday. Sign up here.